XENE Q1 2017 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

XENEXenon Pharmaceuticals Inc.

$5B

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$16,000-97.3% YoY

Gross Profit

-$6M-36793.8% margin

Operating Income

-$8M-49918.8% margin

Net Income

-$8M-46981.3% margin

EPS (Diluted)

$-0.42

QoQ Revenue Growth

-95.7%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$7M

Stock-Based Comp.

$478,000

Balance Sheet

Total Assets

$61M

Total Liabilities

$4M

Stockholders' Equity

$57M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$16,000	$601,000	-97.3%
Gross Profit	-$6M	$312,000	-1986.9%
Operating Income	-$8M	-$6M	-41.2%
Net Income	-$8M	-$3M	-130.4%